These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12958329)

  • 1. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
    Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
    Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
    Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
    Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
    Ratnasabapathy Y; Lawes CM; Anderson CS
    Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
    Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
    Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
    PROGRESS Collaborative Group
    Eur Heart J; 2003 Mar; 24(5):475-84. PubMed ID: 12633548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
    Berthet K; Neal BC; Chalmers JP; MacMahon SW; Bousser MG; Colman SA; Woodward M;
    Blood Press; 2004; 13(1):7-13. PubMed ID: 15083634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
    Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
    Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertension in patients 80 years of age or older.
    Beckett NS; Peters R; Fletcher AE; Staessen JA; Liu L; Dumitrascu D; Stoyanovsky V; Antikainen RL; Nikitin Y; Anderson C; Belhani A; Forette F; Rajkumar C; Thijs L; Banya W; Bulpitt CJ;
    N Engl J Med; 2008 May; 358(18):1887-98. PubMed ID: 18378519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
    Padma MV; Kaul S
    Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
    Scheen AJ; Krzesinski JM
    Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
    Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
    Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.